Overview

A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the clinical effectiveness of oral UFT/LV comparing 5-FU/l-LV as adjuvant therapy for stage III colorectal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Haruhiko Fukuda
Collaborator:
Ministry of Health, Labour and Welfare, Japan
Treatments:
Fluorouracil
Leucovorin
Levoleucovorin